Data / Form D filings / Contraline, Inc.
Contraline, Inc.: Form D filings
Contraline, Inc., a biotechnology company in Charlottesville, VA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on June 10, 2026, reports $55.8 million sold of a $115.9 million offering to 77 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 818 E. Jefferson St Suite 201, Charlottesville, VA, 22902
- Phone
- (347) 327-3676
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1818752
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | New notice | $115,929,658 | $55,804,741 | $60,124,917 | 77 | May 29, 2026 | sec.gov |
| Apr 5, 2022 | New notice | $7,500,000 | $7,225,669 | $274,331 | 22 | Mar 2, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin S Eisenfrats | Executive Officer, Director, Promoter | |
| Martin J Emerson | Director | |
| Gurdane Bhutani | Director | |
| Iris Van Alderwerelt van Rosenburgh | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Contraline, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.